Alembic Pharmaceuticals moves up on getting USFDA’s nod for Dabigatran Etexilate Capsules
Alembic Pharmaceuticals is currently trading at Rs. 873.20, up by 5.75 points or 0.66% from its previous closing of Rs. 867.45 on the BSE. The scrip opened at Rs. 883.25 and has touched a high and low of Rs. 894.00 and Rs. 871.00 respectively. So far 3239 shares were traded on the counter. The BSE … Read more
